The Doherty Institute, a joint venture between The University of Melbourne and the Royal Melbourne Hospital, has been funded through the National Health and Medical Research Council (NHMRC) by the Medical Research Future Fund to conduct a unique Phase I study of two second generation COVID-19 variant vaccines.